Literature DB >> 15691365

Winchester syndrome caused by a homozygous mutation affecting the active site of matrix metalloproteinase 2.

A Zankl1, L Bonafé, V Calcaterra, M Di Rocco, A Superti-Furga.   

Abstract

The inherited osteolysis syndromes are a heterogeneous group of skeletal disorders whose classification is still uncertain. Three osteolysis syndromes show autosomal recessive inheritance and multicentric involvement: Torg syndrome (OMIM 259600), Winchester syndrome (OMIM 277950) and Nodulosis-Arthropathy-Osteolysis syndrome (NAO; OMIM 605156). The 2001 Nosology of the International Skeletal Dysplasia Society (Hall CM, Am J Med Genet 2002: 113: 65) classifies NAO as a variant of Torg syndrome, while Winchester syndrome is considered as a separate disorder. Recently, mutations in the matrix metalloproteinase 2 (MMP2) gene were identified in affected individuals with a clinical diagnosis of NAO in two Arab families. We report a homozygous missense mutation (E404K) in the active site of MMP2 in a 21-year-old woman with a severe form of osteolysis best compatible with a diagnosis of Winchester syndrome. The clinical and molecular findings suggest that Torg, NAO and Winchester syndromes are allelic disorders that form a clinical spectrum.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15691365     DOI: 10.1111/j.1399-0004.2004.00402.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  18 in total

1.  Multicentric carpotarsal osteolysis is caused by mutations clustering in the amino-terminal transcriptional activation domain of MAFB.

Authors:  Andreas Zankl; Emma L Duncan; Paul J Leo; Graeme R Clark; Evgeny A Glazov; Marie-Claude Addor; Troels Herlin; Chong Ae Kim; Bruno P Leheup; Jim McGill; Steven McTaggart; Stephan Mittas; Anna L Mitchell; Geert R Mortier; Stephen P Robertson; Marie Schroeder; Paulien Terhal; Matthew A Brown
Journal:  Am J Hum Genet       Date:  2012-03-01       Impact factor: 11.025

Review 2.  Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted.

Authors:  Kendra J Greenlee; Zena Werb; Farrah Kheradmand
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

3.  Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth.

Authors:  Rebecca A Mosig; Oonagh Dowling; Analisa DiFeo; Maria Celeste M Ramirez; Ian C Parker; Etsuko Abe; Janane Diouri; Aida Al Aqeel; James D Wylie; Samantha A Oblander; Joseph Madri; Paolo Bianco; Suneel S Apte; Mone Zaidi; Stephen B Doty; Robert J Majeska; Mitchell B Schaffler; John A Martignetti
Journal:  Hum Mol Genet       Date:  2007-03-30       Impact factor: 6.150

4.  Functional characterisation of a novel mutation affecting the catalytic domain of MMP2 in siblings with multicentric osteolysis, nodulosis and arthropathy.

Authors:  Jacopo Azzollini; Davide Rovina; Cristina Gervasini; Ilaria Parenti; Alessia Fratoni; Maria Vittoria Cubellis; Amilcare Cerri; Luca Pietrogrande; Lidia Larizza
Journal:  J Hum Genet       Date:  2014-10-02       Impact factor: 3.172

Review 5.  Multicentric osteolysis with nodulosis and arthropathy (MONA) with cardiac malformation, mimicking polyarticular juvenile idiopathic arthritis: case report and literature review.

Authors:  Filip Christian Castberg; Susanne Kjaergaard; Rebecca A Mosig; Mollie Lobl; Chiara Martignetti; John A Martignetti; Charlotte Myrup; Marek Zak
Journal:  Eur J Pediatr       Date:  2013-07-31       Impact factor: 3.183

6.  Matrix Metallopeptidase 2 Gene Polymorphism is Associated with Obesity in Korean Population.

Authors:  Dong Hee Han; Su Kang Kim; Sungwook Kang; Bong-Keun Choe; Keon Sik Kim; Joo-Ho Chung
Journal:  Korean J Physiol Pharmacol       Date:  2008-06-30       Impact factor: 2.016

7.  The diagnosis and management of patients with idiopathic osteolysis.

Authors:  Ali Al Kaissi; Sabine Scholl-Buergi; Rainer Biedermann; Kathrin Maurer; Jochen G Hofstaetter; Klaus Klaushofer; Franz Grill
Journal:  Pediatr Rheumatol Online J       Date:  2011-10-13       Impact factor: 3.054

8.  A novel matrix metalloproteinase 2 (MMP2) terminal hemopexin domain mutation in a family with multicentric osteolysis with nodulosis and arthritis with cardiac defects.

Authors:  Beyhan Tuysuz; Rebecca Mosig; Gürkan Altun; Selim Sancak; Marc J Glucksman; John A Martignetti
Journal:  Eur J Hum Genet       Date:  2008-11-05       Impact factor: 4.246

9.  Clinical and radiographic findings in two brothers affected with a novel mutation in matrix metalloproteinase 2 gene.

Authors:  Faysal Gok; Lauréane Mittaz Crettol; Yasemin Alanay; Bulent Hacihamdioglu; Murat Kocaoglu; Luisa Bonafe; Seza Ozen
Journal:  Eur J Pediatr       Date:  2009-08-04       Impact factor: 3.183

10.  Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development.

Authors:  Mikala Egeblad; H-C Jennifer Shen; Danielle J Behonick; Lisa Wilmes; Alexandra Eichten; Lidiya V Korets; Farrah Kheradmand; Zena Werb; Lisa M Coussens
Journal:  Dev Dyn       Date:  2007-06       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.